Local view for "http://purl.org/linkedpolitics/eu/plenary/2010-11-23-Speech-2-934"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2010-11-23"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"it"^^xsd:language2
lpv:document identification number	"en.20101123.33.2-934"2
lpv:hasSubsequent	lp_eu:2010-11-23-Speech-2-9332
lpv:speaker	lp:Aldo Patriciello2
lpv:spokenAs	member; CONT (2009-07-16--2012-01-18)3 member; ITRE (2009-07-16--2012-01-18)3 substitute; REGI (2009-07-16--2012-01-18)3 substitute; Delegation to the Euronest Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; Delegation to the EU-Armenia, EU-Azerbaijan and EU-Georgia Parliamentary Cooperation Committees (2009-09-16--2014-06-30)3 unknown; Il Popolo della Libertà (2009-07-14--2013-12-05)3 member; Delegation for relations with Albania, Bosnia and Herzegovina, Serbia, Montenegro and Kosovo (2009-09-16--2014-06-30)3 member; EPP (2009-07-14--2014-06-30)3
lpv:translated text	"As well as congratulating the rapporteur, Mr Moreira, with whom I agree on the need for periodic reviews to update the lists of pharmaceutical products eligible for duty-free treatment, I must point out that, thanks to the new mechanism introduced, end consumers will be the ones who benefit. Indeed, I voted in favour because I believe it is important to periodically review the list of pharmaceutical products that are exempt from customs duties, in view of the rapidly changing product environment in the pharmaceutical industry. All Member States have supported previous reviews and support the product coverage of the fourth review. I therefore commend the work done and confirm my vote in favour."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph